| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 23.90▼ | 23.88▼ | 23.82▼ | 22.73▲ | 21.98▲ |
| MA10 | 23.99▼ | 23.77▲ | 23.79▼ | 22.24▲ | 21.15▲ |
| MA20 | 23.92▼ | 23.77▲ | 23.02▲ | 21.67▲ | 18.43▲ |
| MA50 | 23.75▲ | 22.86▲ | 22.27▲ | 20.76▲ | N/A |
| MA100 | 23.84▼ | 22.19▲ | 22.28▲ | N/A | N/A |
| MA200 | 23.03▲ | 22.13▲ | 21.54▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.025▼ | -0.036▼ | 0.029▲ | 0.100▲ | N/A |
| RSI | 44.663▼ | 54.492▲ | 57.958▲ | 59.387▲ | 69.736▲ |
| STOCH | 24.262 | 69.436 | 51.017 | 51.010 | 73.733 |
| WILL %R | -92.405▼ | -46.753 | -40.042 | -20.304▲ | -10.626▲ |
| CCI | -145.467▼ | 56.616 | 16.336 | 126.697▲ | 109.557▲ |
| ▲ PSAR&MOM | $LBRX PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&MACD | $LBRX MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $LBRX RSI Cross Up and Volume | Set Alert |
| RSI | $LBRX RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $LBRX MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $LBRX Price Crossed Above MA(26) | Set Alert |
| MA | $LBRX Price Crossed Above MA(13) | Set Alert |
| MA | $LBRX Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $LBRX Open Gap Up %5 | Set Alert |
| ▲ GAP | $LBRX Open Gap Up %3 | Set Alert |
| ▲ GAP | $LBRX Open Gap Up %2 | Set Alert |
|
Thursday, February 05, 2026 05:18 AM
LB Pharmaceuticals intends to use the net proceeds from the private placement to fund a Phase 2 trial for LB-102 as an adjunctive treatment for major depressive disorder, and for working capital and ...
|
|
Monday, January 26, 2026 05:32 AM
Topline data expected in 1Q 2028 Phase 2 bipolar depression trial initiation follows positive Phase 2 results in acute schizophrenia NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ...
|
|
Monday, January 12, 2026 08:06 AM
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Ellen Rose, the new Senior Vice ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 24.03 | 24.53 | 23.165 | 23.82 | 263,835 |
| 05/02/26 | 22.38 | 24.9499 | 22.00 | 23.86 | 416,771 |
| 04/02/26 | 22.06 | 23.15 | 20.65 | 21.17 | 84,908 |
| 03/02/26 | 22.91 | 23.50 | 21.65 | 21.87 | 144,658 |
| 02/02/26 | 21.47 | 23.04 | 21.16 | 22.91 | 193,194 |
| 30/01/26 | 21.01 | 21.78 | 20.46 | 21.45 | 157,284 |
| 29/01/26 | 21.22 | 21.785 | 20.80 | 21.17 | 130,642 |
| 28/01/26 | 22.80 | 22.82 | 20.81 | 21.24 | 120,232 |
| 27/01/26 | 22.32 | 22.835 | 21.885 | 22.53 | 143,504 |
| 26/01/26 | 24.00 | 24.00 | 21.82 | 22.38 | 187,228 |
|
|
||||
|
|
||||
|
|